Company (Symbol) | Product | Description | Indication | Action/Date |
Cell Pathways Inc. (CLPA) | Aptosyn | Small-molecule compound that augments apoptosis | Familial polyposis | FDA told the company its NDA is not approvable due to deficiencies (9/22) |
Subscribe to BioWorld™ news services
Company (Symbol) | Product | Description | Indication | Action/Date |
Cell Pathways Inc. (CLPA) | Aptosyn | Small-molecule compound that augments apoptosis | Familial polyposis | FDA told the company its NDA is not approvable due to deficiencies (9/22) |